Nurix Therapeutics Inc
NASDAQ:NRIX

Watchlist Manager
Nurix Therapeutics Inc Logo
Nurix Therapeutics Inc
NASDAQ:NRIX
Watchlist
Price: 24.58 USD 2.12% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Nurix Therapeutics Inc?
Write Note

Nurix Therapeutics Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nurix Therapeutics Inc
Selling, General & Administrative Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Nurix Therapeutics Inc
NASDAQ:NRIX
Selling, General & Administrative
-$42.9m
CAGR 3-Years
-38%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Selling, General & Administrative
-$13.1B
CAGR 3-Years
-3%
CAGR 5-Years
-13%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Selling, General & Administrative
-$5.6B
CAGR 3-Years
-2%
CAGR 5-Years
-6%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Selling, General & Administrative
-$7.2B
CAGR 3-Years
-8%
CAGR 5-Years
-6%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Selling, General & Administrative
-$1.3B
CAGR 3-Years
-20%
CAGR 5-Years
-18%
CAGR 10-Years
-16%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Selling, General & Administrative
-$2.8B
CAGR 3-Years
-25%
CAGR 5-Years
-14%
CAGR 10-Years
-22%

See Also

What is Nurix Therapeutics Inc's Selling, General & Administrative?
Selling, General & Administrative
-42.9m USD

Based on the financial report for Nov 30, 2023, Nurix Therapeutics Inc's Selling, General & Administrative amounts to -42.9m USD.

What is Nurix Therapeutics Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-45%

Over the last year, the Selling, General & Administrative growth was -13%. The average annual Selling, General & Administrative growth rates for Nurix Therapeutics Inc have been -38% over the past three years , -45% over the past five years .

Back to Top